Skip to main content
PMC home page
Medical History logoLink to Medical History
. 2003 Jul;47(3):291–313.

Beyond "bad news": the diagnosis, prognosis and classification of lymphomas and lymphoma patients in the age of biomedicine (1945-1995).

Peter Keating 1, Alberto Cambrosio 1
PMCID: PMC1044630  PMID: 12905916

Full text

PDF
312

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banfi A., Bonadonna G., Buraggi G., Chiappa S., Di Pietro S., Felci U., Giacomelli V., Pizzetti F., Uslenghi C., Veronesi U. Proposta di classificazione e criteri terapeutici del linfosarcoma e del reticolosarcoma. Tumori. 1965 May-Jun;51(3):153–177. doi: 10.1177/030089166505100301. [DOI] [PubMed] [Google Scholar]
  2. Bonadonna G. Historical review of Hodgkin's disease. Br J Haematol. 2000 Sep;110(3):504–511. doi: 10.1046/j.1365-2141.2000.02197.x. [DOI] [PubMed] [Google Scholar]
  3. Boston H. C., Jr, Dahlin D. C., Ivins J. C., Cupps R. E. Malignant lymphoma (so-called reticulum cell sarcoma) of bone. Cancer. 1974 Oct;34(4):1131–1137. doi: 10.1002/1097-0142(197410)34:4<1131::aid-cncr2820340424>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  4. Bouroncle B. A. Sternberg-Reed cells in the peripheral blood of patients with Hodgkin's disease. Blood. 1966 Apr;27(4):544–556. [PubMed] [Google Scholar]
  5. Chaffey J. T., Hellman S., Rosenthal D. S., Moloney W. C. Total-body irradiation in the treatment of lymphocytic lymphoma. Cancer Treat Rep. 1977 Sep;61(6):1149–1152. [PubMed] [Google Scholar]
  6. Chim C. S., Kwong Y. L., Lie A. K., Lee C. K., Liang R. CEOP treatment results and validity of the International Prognostic Index in Chinese patients with aggressive non-Hodgkin's lymphoma. Hematol Oncol. 1998 Sep;16(3):117–123. doi: 10.1002/(sici)1099-1069(199809)16:3<117::aid-hon632>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  7. Christakis N. A., Sachs G. A. The role of prognosis in clinical decision making. J Gen Intern Med. 1996 Jul;11(7):422–425. doi: 10.1007/BF02600190. [DOI] [PubMed] [Google Scholar]
  8. Christakis N. A. The ellipsis of prognosis in modern medical thought. Soc Sci Med. 1997 Feb;44(3):301–315. doi: 10.1016/s0277-9536(96)00100-1. [DOI] [PubMed] [Google Scholar]
  9. DeVita V. T., Jr, Canellos G. P. The lymphomas. Semin Hematol. 1999 Oct;36(4 Suppl 7):84–94. [PubMed] [Google Scholar]
  10. Ezdinli E. Z., Costello W., Wasser L. P., Lenhard R. E., Berard C. W., Hartsock R., Bennett J. M., Carbone P. P. Eastern Cooperative Oncology Group experience with the rappaport classification of non-Hodgkin's lymphomas. Cancer. 1979 Feb;43(2):544–550. doi: 10.1002/1097-0142(197902)43:2<544::aid-cncr2820430221>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  11. Goffinet D. R., Warnke R., Dunnick N. R., Castellino R., Glatstein E., Nelsen T. S., Dorfman R. F., Rosenberg S. A., Kaplan H. S. Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas. Cancer Treat Rep. 1977 Sep;61(6):981–992. [PubMed] [Google Scholar]
  12. Gospodarowicz M., Mackillop W., O'Sullivan B., Sobin L., Henson D., Hutter R. V., Wittekind C. Prognostic factors in clinical decision making: the future. Cancer. 2001 Apr 15;91(8 Suppl):1688–1695. doi: 10.1002/1097-0142(20010415)91:8+<1688::aid-cncr1184>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  13. HICKS E. B., RAPPAPORT H., WINTER W. J. Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer. 1956 Jul-Aug;9(4):792–821. doi: 10.1002/1097-0142(195607/08)9:4<792::aid-cncr2820090429>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  14. Hansen H. S. Reticulum cell sarcoma treated by radiotherapy. Significance of clinical features upon the prognosis. Acta Radiol Ther Phys Biol. 1969 Dec;8(6):439–458. doi: 10.3109/02841866909134471. [DOI] [PubMed] [Google Scholar]
  15. Harris N. L., Jaffe E. S., Diebold J., Flandrin G., Muller-Hermelink H. K., Vardiman J., Lister T. A., Bloomfield C. D. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol. 1999 Dec;10(12):1419–1432. doi: 10.1023/a:1008375931236. [DOI] [PubMed] [Google Scholar]
  16. Harris N. L. The many faces of Hodgkin's disease around the world: what have we learned from its pathology? Ann Oncol. 1998;9 (Suppl 5):S45–S56. doi: 10.1093/annonc/9.suppl_5.s45. [DOI] [PubMed] [Google Scholar]
  17. Hasenclever D., Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med. 1998 Nov 19;339(21):1506–1514. doi: 10.1056/NEJM199811193392104. [DOI] [PubMed] [Google Scholar]
  18. Hellman S. Current studies in Hodgkin's disease: what laparotomy has wrought. N Engl J Med. 1974 Apr 18;290(16):894–898. doi: 10.1056/NEJM197404182901609. [DOI] [PubMed] [Google Scholar]
  19. Hilden J., Habbema D. F. Prognosis in medicine: an analysis of its meaning and roles. Theor Med. 1987 Oct;8(3):349–365. doi: 10.1007/BF00489469. [DOI] [PubMed] [Google Scholar]
  20. Johnson R. E., O'Conor G. T., Levin D. Primary management of advanced lymphosarcoma with radiotherapy. Cancer. 1970 Apr;25(4):787–791. doi: 10.1002/1097-0142(197004)25:4<787::aid-cncr2820250407>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  21. Johnson R. E., O'Conor G. T., Levin D. Primary management of advanced lymphosarcoma with radiotherapy. Cancer. 1970 Apr;25(4):787–791. doi: 10.1002/1097-0142(197004)25:4<787::aid-cncr2820250407>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  22. Jones S. E., Butler J. J., Byrne G. E., Jr, Coltman C. A., Jr, Moon T. E. Histopathologic review of lymphoma cases from the Southwest Oncology Group. Cancer. 1977 Mar;39(3):1071–1076. doi: 10.1002/1097-0142(197703)39:3<1071::aid-cncr2820390310>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  23. KINMONTH J. B., TAYLOR G. W., HARPER R. K. Lymphangiography; a technique for its clinical use in the lower limb. Br Med J. 1955 Apr 16;1(4919):940–942. doi: 10.1136/bmj.1.4919.940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kaplan H. S., Rosenberg S. A. Extended-field radical radiotherapy in advanced Hodgkin's disease: short-term results of 2 randomized clinical trials. Cancer Res. 1966 Jun;26(6):1268–1276. [PubMed] [Google Scholar]
  25. Karnofsky D. A. The staging of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1090–1094. [PubMed] [Google Scholar]
  26. Keating Peter, Cambrosio Alberto. From screening to clinical research: the cure of leukemia and the early development of the cooperative oncology groups, 1955-1966. Bull Hist Med. 2002 Summer;76(2):299–334. doi: 10.1353/bhm.2002.0074. [DOI] [PubMed] [Google Scholar]
  27. LUKES R. J. HODGKIN'S DISEASE. PROGNOSIS AND RELATIONSHIP OF HISTOLOGIC FEATURES TO CLINICAL STAGE. JAMA. 1964 Dec 7;190:914–915. doi: 10.1001/jama.1964.03070230050014. [DOI] [PubMed] [Google Scholar]
  28. LUKES R. J. RELATIONSHIP OF HISTOLOGIC FEATURES TO CLINICAL STAGES IN HODGKIN'S DISEASE. Am J Roentgenol Radium Ther Nucl Med. 1963 Nov;90:944–955. [PubMed] [Google Scholar]
  29. Lennert K. Die Beziehungen von Hodgkin- und Non-Hodgkin-Lymphomen. Arzneimittelforschung. 1987 Feb;37(2A):255–259. [PubMed] [Google Scholar]
  30. Lipton A., Lee B. J. Prognosis of stage I lymphosarcoma and reticulum-cell sarcoma. N Engl J Med. 1971 Feb 4;284(5):230–233. doi: 10.1056/NEJM197102042840502. [DOI] [PubMed] [Google Scholar]
  31. Lotz M. J., Chabner B., DeVita V. T., Jr, Johnson R. E., Berard C. W. Pathological staging of 100 consecutive untreated patients with non-Hodgkin's lymphomas: extramedullary sites of disease. Cancer. 1976 Jan;37(1):266–270. doi: 10.1002/1097-0142(197601)37:1<266::aid-cncr2820370136>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  32. Lukes R. J., Butler J., Hicks E. B. Le pronostic de la maladie de Hodgkin d'après la variété histologique et le stade clinique. Rôle des réactions de l'hôte. Nouv Rev Fr Hematol. 1966 Jan-Feb;6(1):15–22. [PubMed] [Google Scholar]
  33. Lukes R. J., Gompel C., Nezelof C. Le diagnostic histopathologique de la maladie de Hodgkin. Analyse préliminaire d'une étude conduite à l'aveugle sur 395 observations, par trois pathologistes de nationalité différente. Nouv Rev Fr Hematol. 1966 Jan-Feb;6(1):11–14. [PubMed] [Google Scholar]
  34. Lukes R. J., Taylor C. R., Parker J. W., Lincoln T. L., Pattengale P. K., Tindle B. H. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Am J Pathol. 1978 Feb;90(2):461–486. [PMC free article] [PubMed] [Google Scholar]
  35. Miller T. R., Nicholson J. T. End results in reticulum cell sarcoma of bone treated by bacterial toxin therapy alone or combined with surgery and-or radiotherapy (47 cases) or with concurrent infection (5 cases). Cancer. 1971 Mar;27(3):524–548. doi: 10.1002/1097-0142(197103)27:3<524::aid-cncr2820270305>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  36. Moormeier J. A., Williams S. F., Golomb H. M. The staging of non-Hodgkin's lymphomas. Semin Oncol. 1990 Feb;17(1):43–50. [PubMed] [Google Scholar]
  37. Muggia F. M., Davis H. L., Jr, Rozencweig M. Current cooperative clinical trials in the non-Hodgkin's lymphomas. Cancer Treat Rep. 1977 Sep;61(6):1191–1197. [PubMed] [Google Scholar]
  38. Ménoret Marie. The genesis of the notion of stages in oncology: the French Permanent Cancer Survey (1943-1952). Soc Hist Med. 2002 Aug;15(2):291–302. doi: 10.1093/shm/15.2.291. [DOI] [PubMed] [Google Scholar]
  39. Nathwani B. N., Dixon D. O., Jones S. E., Hartsock R. J., Rebuck J. W., Byrne G. E., Jr, Sheehan W. W., Kim H., Coltman C. A., Jr, Rappaport H. The clinical significance of the morphological subdivision of diffuse "histiocytic" lymphoma: a study of 162 patients treated by the Southwest Oncology Group. Blood. 1982 Nov;60(5):1068–1074. [PubMed] [Google Scholar]
  40. Newall J., Friedman M. Reticulum-cell sarcoma. 3. Prognosis. Radiology. 1970 Oct;97(1):99–102. doi: 10.1148/97.1.99. [DOI] [PubMed] [Google Scholar]
  41. Nissen N. I., Pajak T., Glidewell O., Blom H., Flaherty M., Hayes D., McIntyre R., Holland J. F. Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B. Cancer Treat Rep. 1977 Sep;61(6):1097–1107. [PubMed] [Google Scholar]
  42. PETERS M. V., MIDDLEMISS K. C. A study of Hodgkin's disease treated by irradiation. Am J Roentgenol Radium Ther Nucl Med. 1958 Jan;79(1):114–121. [PubMed] [Google Scholar]
  43. Peters M. V. Prophylactic treatment of adjacent areas in Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1232–1243. [PubMed] [Google Scholar]
  44. Poston R. N. A new look at the original cases of Hodgkin's disease. Cancer Treat Rev. 1999 Jun;25(3):151–155. doi: 10.1053/ctrv.1998.9997. [DOI] [PubMed] [Google Scholar]
  45. Rizzi D. A. Medical prognosis--some fundamentals. Theor Med. 1993 Dec;14(4):365–375. doi: 10.1007/BF00996342. [DOI] [PubMed] [Google Scholar]
  46. Rosenberg S. A., Kaplan H. S. Evidence for an orderly progression in the spread of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1225–1231. [PubMed] [Google Scholar]
  47. Roth S. L., Sack H., Havemann K., Willers R., Kocsis B., Schumacher V. Contiguous pattern spreading in patients with Hodgkin's disease. Radiother Oncol. 1998 Apr;47(1):7–16. doi: 10.1016/s0167-8140(97)00208-9. [DOI] [PubMed] [Google Scholar]
  48. Stelitano C., Baldini L., Pieresca C., Callea V., Angrilli F., Clò V., Partesotti G., Merli F., Cavanna L., Morabito F. Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry. Haematologica. 2000 Feb;85(2):154–159. [PubMed] [Google Scholar]
  49. Strauchen J. A., Young R. C., DeVita V. T., Jr, Anderson T., Fantone J. C., Berard C. W. Clinical relevance of the histopathological subclassification of diffuse "histiocytic" lymphoma. N Engl J Med. 1978 Dec 21;299(25):1382–1387. doi: 10.1056/NEJM197812212992503. [DOI] [PubMed] [Google Scholar]
  50. Tikka U., Malmio K. Clinical and radiotherapeutic aspects of reticulum cell sarcoma. Acta Radiol Ther Phys Biol. 1969 Dec;8(6):459–470. doi: 10.3109/02841866909134472. [DOI] [PubMed] [Google Scholar]
  51. Ultmann J. E., Moran E. M. Diagnostic evaluation and clinical staging in Hodgkin's disease: usefulness and problems of the Ann Arbor staging classification in primary staging and staging in relapse. Natl Cancer Inst Monogr. 1973 May;36:333–345. doi: 10.2172/4582994. [DOI] [PubMed] [Google Scholar]
  52. Wang C. C., Fleischli D. J. Primary reticulum cell sarcoma of bone. With emphasis on radiation therapy. Cancer. 1968 Nov;22(5):994–998. doi: 10.1002/1097-0142(196811)22:5<994::aid-cncr2820220514>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  53. Young R. C., Johnson R. E., Canellos G. P., Chabner B. A., Brereton H. D., Berard C. W., DeVita V. T. Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination. Cancer Treat Rep. 1977 Sep;61(6):1153–1159. [PubMed] [Google Scholar]

Articles from Medical History are provided here courtesy of Cambridge University Press

RESOURCES